Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,696.80
(
-0.42%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
111.47
(
4.58%
)
Bitcoin
70,033.11
(
-1.70%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 72376

Thursday, 01/29/2009 6:11:06 PM

Thursday, January 29, 2009 6:11:06 PM

Post# of 257257

AstraZeneca is doubling the size of its cost-cutting plan-which means another 7,400 or so jobs face the ax by 2013.

What’s notable about this is that the cuts are not limited to sales and marketing; rather, some of them will be in R&D (see next post), as is the case with PFE’s recently announced cutback.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now